Last CNY16.25 CNY
Change Today -0.23 / -1.40%
Volume 2.3M
002412 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 2:00 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

hunan hansen pharmaceutica-a (002412) Snapshot

Open
CNY16.48
Previous Close
CNY16.48
Day High
CNY16.48
Day Low
CNY16.20
52 Week High
10/16/14 - CNY20.30
52 Week Low
04/29/14 - CNY14.00
Market Cap
4.8B
Average Volume 10 Days
3.6M
EPS TTM
CNY0.43
Shares Outstanding
296.0M
EX-Date
05/23/14
P/E TM
37.7x
Dividend
CNY0.25
Dividend Yield
1.54%
Current Stock Chart for HUNAN HANSEN PHARMACEUTICA-A (002412)

Related News

No related news articles were found.

hunan hansen pharmaceutica-a (002412) Related Businessweek News

No Related Businessweek News Found

hunan hansen pharmaceutica-a (002412) Details

Hunan Hansen Pharmaceutical Co., Ltd. is engaged in the research, development, production, and distribution of Chinese traditional medicines for the treatment of gastrointestinal, orthopedic traumatism, cardiovascular, cerebrovascular, and other diseases. It produces various forms of medicine, including tablets, capsules, granules, pills, soft extracts, syrups, oral liquids, tinctures, large-volume and small-volume injections, psychotropic substances, and bulk drugs, as well as others. The company’s principal products include Simotang oral liquid used to treat abdominal distention and phlegmatic abdominalgia; Yushangling capsules used for injuries from falls; Yinxingye capsules for stroke and chest distress; Suoquan capsules used for kidney deficiency; respiratory system drugs; traumatology medication products; and diagnostic agents. Hunan Hansen Pharmaceutical Co., Ltd. is based in Yiyang, China.

hunan hansen pharmaceutica-a (002412) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hunan hansen pharmaceutica-a (002412) Key Developments

Hunan Sany Intelligent Control and Automation Equipment to Establish Bank JV

Sany Heavy Industry said that its wholly-owned subsidiary Hunan Sany Intelligent Control and Automation Equipment planned to establish Sanxiang Bank with Sany Group, Hunan Hansen Pharmaceutical, Yonker Environmental Protection, and Gongchuang Group. Registered capital of the bank is CNY 3 billion. Sany Automation and Sany Group each will control a 12% and an 18% stake with investment of CNY 360 million and CNY 540 million.

Hunan Hansen Pharmaceutical Co., Ltd. to Report Q3, 2014 Results on Oct 27, 2014

Hunan Hansen Pharmaceutical Co., Ltd. announced that they will report Q3, 2014 results on Oct 27, 2014

Hunan Hansen Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Sep 05, 2014

Hunan Hansen Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Sep 05, 2014., at 15:00 China Standard Time. Agenda: To consider the use of partial excessive raised funds for the transformation of an old workshop; and to consider the use of partial excessive raised funds for the investment in setup of a wholly-owned subsidiary.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002412:CH CNY16.25 CNY -0.23

002412 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002412.
View Industry Companies
 

Industry Analysis

002412

Industry Average

Valuation 002412 Industry Range
Price/Earnings 39.7x
Price/Sales 7.1x
Price/Book 4.5x
Price/Cash Flow 39.8x
TEV/Sales 6.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HUNAN HANSEN PHARMACEUTICA-A, please visit www.hansenzy.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.